Učitavanje...
Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG
BACKGROUND: The question of how to set the cost-effectiveness threshold for new, innovative medicines is a matter of ongoing controversy. One prominent proposal suggests that the cost-effectiveness threshold adopted by the U.K. National Institute for Health and Care Excellence (NICE) should represen...
Spremljeno u:
| Izdano u: | BMC Health Serv Res |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7178559/ https://ncbi.nlm.nih.gov/pubmed/32321496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-020-5050-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|